Literature DB >> 26289315

The dynamic control of signal transduction networks in cancer cells.

Walter Kolch1,2,3, Melinda Halasz1, Marina Granovskaya4, Boris N Kholodenko1,2,3.   

Abstract

Cancer is often considered a genetic disease. However, much of the enormous plasticity of cancer cells to evolve different phenotypes, to adapt to challenging microenvironments and to withstand therapeutic assaults is encoded by the structure and spatiotemporal dynamics of signal transduction networks. In this Review, we discuss recent concepts concerning how the rich signalling dynamics afforded by these networks are regulated and how they impinge on cancer cell proliferation, survival, invasiveness and drug resistance. Understanding this dynamic circuitry by mathematical modelling could pave the way to new therapeutic approaches and personalized treatments.

Entities:  

Mesh:

Year:  2015        PMID: 26289315     DOI: 10.1038/nrc3983

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  142 in total

1.  A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells.

Authors:  Wenwei Hu; Zhaohui Feng; Lan Ma; John Wagner; J Jeremy Rice; Gustavo Stolovitzky; Arnold J Levine
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

Review 2.  The ins and outs of the epithelial to mesenchymal transition in health and disease.

Authors:  M Angela Nieto
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-08       Impact factor: 13.827

Review 3.  Phosphorylation network dynamics in the control of cell cycle transitions.

Authors:  Daniel Fisher; Liliana Krasinska; Damien Coudreuse; Béla Novák
Journal:  J Cell Sci       Date:  2012-10-15       Impact factor: 5.285

4.  Realistic control of network dynamics.

Authors:  Sean P Cornelius; William L Kath; Adilson E Motter
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 5.  Genetically encoded molecular probes to visualize and perturb signaling dynamics in living biological systems.

Authors:  Vedangi Sample; Sohum Mehta; Jin Zhang
Journal:  J Cell Sci       Date:  2014-03-15       Impact factor: 5.285

6.  Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

Authors:  Suzanne Carreira; Jane Goodall; Laurence Denat; Mercedes Rodriguez; Paolo Nuciforo; Keith S Hoek; Alessandro Testori; Lionel Larue; Colin R Goding
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

7.  Regulation of Raf-1 activation and signalling by dephosphorylation.

Authors:  Amardeep S Dhillon; Sharon Meikle; Zihni Yazici; Manfred Eulitz; Walter Kolch
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

8.  Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

Authors:  Alexa B Turke; Kreshnik Zejnullahu; Yi-Long Wu; Youngchul Song; Dora Dias-Santagata; Eugene Lifshits; Luca Toschi; Andrew Rogers; Tony Mok; Lecia Sequist; Neal I Lindeman; Carly Murphy; Sara Akhavanfard; Beow Y Yeap; Yun Xiao; Marzia Capelletti; A John Iafrate; Charles Lee; James G Christensen; Jeffrey A Engelman; Pasi A Jänne
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

9.  Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

Authors:  Michael J Lee; Albert S Ye; Alexandra K Gardino; Anne Margriet Heijink; Peter K Sorger; Gavin MacBeath; Michael B Yaffe
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

10.  Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses.

Authors:  Marc R Birtwistle; Mariko Hatakeyama; Noriko Yumoto; Babatunde A Ogunnaike; Jan B Hoek; Boris N Kholodenko
Journal:  Mol Syst Biol       Date:  2007-11-13       Impact factor: 11.429

View more
  106 in total

Review 1.  Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub.

Authors:  Peter Csermely; Tamás Korcsmáros; Ruth Nussinov
Journal:  Semin Cell Dev Biol       Date:  2016-07-06       Impact factor: 7.727

2.  Kinetic Modeling and Analysis of the Akt/Mechanistic Target of Rapamycin Complex 1 (mTORC1) Signaling Axis Reveals Cooperative, Feedforward Regulation.

Authors:  Anisur Rahman; Jason M Haugh
Journal:  J Biol Chem       Date:  2017-01-09       Impact factor: 5.157

3.  Representing dynamic biological networks with multi-scale probabilistic models.

Authors:  Alexander Groß; Barbara Kracher; Johann M Kraus; Silke D Kühlwein; Astrid S Pfister; Sebastian Wiese; Katrin Luckert; Oliver Pötz; Thomas Joos; Dries Van Daele; Luc De Raedt; Michael Kühl; Hans A Kestler
Journal:  Commun Biol       Date:  2019-01-17

Review 4.  Network biology concepts in complex disease comorbidities.

Authors:  Jessica Xin Hu; Cecilia Engel Thomas; Søren Brunak
Journal:  Nat Rev Genet       Date:  2016-08-08       Impact factor: 53.242

5.  A novel algorithm for finding optimal driver nodes to target control complex networks and its applications for drug targets identification.

Authors:  Wei-Feng Guo; Shao-Wu Zhang; Qian-Qian Shi; Cheng-Ming Zhang; Tao Zeng; Luonan Chen
Journal:  BMC Genomics       Date:  2018-01-19       Impact factor: 3.969

6.  Feedback analysis identifies a combination target for overcoming adaptive resistance to targeted cancer therapy.

Authors:  Sang-Min Park; Chae Young Hwang; Jihye Choi; Chang Young Joung; Kwang-Hyun Cho
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

Review 7.  New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.

Authors:  Keesha E Erickson; Oleksii S Rukhlenko; Richard G Posner; William S Hlavacek; Boris N Kholodenko
Journal:  Semin Cancer Biol       Date:  2018-03-05       Impact factor: 15.707

8.  A Real-Time Biosensor for ERK Activity Reveals Signaling Dynamics during C. elegans Cell Fate Specification.

Authors:  Claire de la Cova; Robert Townley; Sergi Regot; Iva Greenwald
Journal:  Dev Cell       Date:  2017-08-17       Impact factor: 12.270

9.  Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers.

Authors:  Chaoyang Sun; Yong Fang; Jun Yin; Jian Chen; Zhenlin Ju; Dong Zhang; Xiaohua Chen; Christopher P Vellano; Kang Jin Jeong; Patrick Kwok-Shing Ng; Agda Karina B Eterovic; Neil H Bhola; Yiling Lu; Shannon N Westin; Jennifer R Grandis; Shiaw-Yih Lin; Kenneth L Scott; Guang Peng; Joan Brugge; Gordon B Mills
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

10.  Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype.

Authors:  Tong Xu; Hong-Tao Li; Jenny Wei; Meng Li; Tien-Chan Hsieh; Yi-Tsung Lu; Ranjani Lakshminarasimhan; Rong Xu; Emmanuelle Hodara; Gareth Morrison; Hemant Gujar; Suhn Kyong Rhie; Kimberly Siegmund; Gangning Liang; Amir Goldkorn
Journal:  Int J Cancer       Date:  2020-02-22       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.